A NEW ASSOCIATION OF COMPONENTS THAT IS ABLE TO BLOCK MIGRAINE AUTA AND TO PREVENT MIGRAIN THROUGH A CENTRAL NEURAL MODULATION AND A PERIPHERAL DESENSITIZAZION.
AURAStop for the treatment of migraine aura.
Mode of use: 1 tablet at the beginning of aura followed by 1 tablet at the beginning of pain.
The aura is an electrical phenomenon that involves specific areas of the cerebral cortex, expanding gradually from the occipital lobe (back part of the brain) to the frontal lobe (front part of the brain) leading to deficits in the functioning of the brain structures involved.
About 1/4 of migraineurs have migraine with aura, that is, more than 2.5 million people in Italy.
Aurastop in the prevention of migraine with and without aura
Mode of use: 1 tablet 2 times daily for 3 months.
The negative impact on the quality of life and the social costs of migraine - the World Health Organization ranks migraine among the top ten most disabling diseases - makes it essential to correctly classify primary headaches, through the involvement of specialized centers dedicated to the study of headaches.
The diagnosis of migraine is also crucial to allow an appropriate therapeutic approach to prevention which is currently based on a wide range of compounds or specific drugs.
Aurastop in the treatment of menstrual migraine
Mode of use: 1 tablet 2 times daily from the second day before menstruation to the end of the menstrual cycle.
Menstrual migraine is a form of headache that affects women of childbearing age during the menstrual cycle.
Aurastop in the treatment of acute attacks of headache
Mode of use: 2 tablets together.
To be used when the pain is of mild to medium intensity or in pediatric patients or over 65 years of age. It can be used in the presence of cardiovascular diseases, gastric diseases, liver failure or renal failure (when many analgesics or triptans are contraindicated).
Aurastop in children
A natural adjuvant for the treatment of headache in this age category.